Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1031210190Not yet recruiting
Open-label, single-arm trial of cefmetazole, chlorhexidine, propofol, midazolam, remimazolam and 1 more in anaphylaxis, sponsored by Japan Society for the Promotion of Science. Planned start Jul 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1031210190.